retatrutide compounding pharmacy Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial GLP-3: RT - Simon's Compounding
Description
Total Medicaid drug spending rose to $6 billion in 2025 from $4.8 billion in 2022, according to data provided by the Pennsylvania Department of Human Services
Pharmas relentless push to go from 2x/day (730/year) to 1x/week (52/year) and eventually to monthly and yearly can dramatically reduce the overall burden of managing a chronic disease for patients, significantly increasing persistence and therefore efficacy of the treatment and ultimately, healthspan and lifespan
She also said she has a nutritionist and a therapist specializing in EDs to help her as she learns body acceptance
GLP-1 drugs work through a completely different mechanism than thyroid hormonethey slow gastric emptying, reduce hunger signals in the brain, and improve blood sugar control
Human data from diabetics suggest longer lifespans compared to non-diabetics, but its unclear if this applies to healthy people
Week 10 and beyond: the new normal Some level of slower transit may persist for the duration of treatment
